stem cells to reverse Effects of Emphysema

Transplantation of Autologous Stem Cells Found to Reverse Effects of Emphysema

A novel stem cell therapy could be a viable treatment for patients with emphysema.   Previous methods to treat advanced lung disease involved transplanting stem cells intravenously.  In this new study, researchers used an endoscopic delivery system coupled with a scaffold comprised of natural extracellular matrix components to transplant autologous lung-derived mesenchymal stem cells (LMSCs) into the lungs of [animal] subjects with emphysema.  Post-transplantation results indicated marked evidence of tissue regeneration, increased blood flow to the lungs, and increased extra cellular matrix content.

 ”Mensenchymal stem cells are considered for transplantation because they are readily available, highly proliferative and display multi-lineage potential,” said study corresponding author Dr. Edward P. Ingenito of the Brigham and Women’s Hospital Division of Pulmonary and Critical Care Medicine.
The study is indicative of the multidisciplinary approach to the usage of autologous stem cells opening the door to a multitude of new possibilities for innovative stem cell therapies in a biologically organic way: using the body’s own regenerative properties to heal itself through the unique power of stem cells.


Preserving one’s own mesenchymal stem cells provides biological insurance for families and assurance that they will have access to progressive therapies when they need them most.  Banking the highly proliferative mesenchymal stem cells found in the dental pulp of baby teeth and wisdom teeth is an easy and affordable way to insure the future health of your family.
To learn more about how to bank dental stem cells, visit www.stemsave.com or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now.